NCT06356233View on ClinicalTrials.gov

Phenotyping and Identification of Biological Markers in STXBP1 Encephalopathy

Not yet recruitingOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

October 1, 2027

Study Completion Date

December 31, 2027

Conditions
STXBP1 Encephalopathy With Epilepsy
Interventions
OTHER

No intervention will be performed

No intervention will be performed

Trial Locations (1)

28034

Hospital Ruber Internacional, Madrid

All Listed Sponsors
lead

Fundación Iniciativa para las Neurociencias (FINCE)

OTHER

NCT06356233 - Phenotyping and Identification of Biological Markers in STXBP1 Encephalopathy | Biotech Hunter | Biotech Hunter